Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
Amazon
AMZN
|
+$241M |
| 4 |
Procter & Gamble
PG
|
+$212M |
| 5 |
Verizon
VZ
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$841M |
| 2 |
MON
Monsanto Co
MON
|
+$592M |
| 3 |
Apple
AAPL
|
+$138M |
| 4 |
Royal Bank of Canada
RY
|
+$82.4M |
| 5 |
CSRA
CSRA Inc.
CSRA
|
+$77.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.98% |
| 2 | Financials | 15.74% |
| 3 | Healthcare | 13.25% |
| 4 | Consumer Discretionary | 10.32% |
| 5 | Industrials | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSL
1976
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $8.53M | ﹤0.01% |
689,829
+82,959
| +14% | +$967K |
|
|
CARO
1977
DELISTED
Carolina Financial Corp.
CARO
| $8.52M | ﹤0.01% |
198,615
+38,084
| +24% | +$1.58M |
|
1978
GSK
GSK
$103B
| $8.51M | ﹤0.01% |
168,942
+22,860
| +16% | +$1.15M |
|
|
FSCT
1979
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $8.44M | ﹤0.01% |
246,445
+101,502
| +70% | +$3.3M |
|
|
DBD
1980
DELISTED
Diebold Nixdorf Incorporated
DBD
| $8.44M | ﹤0.01% |
706,356
+86,290
| +14% | +$1.15M |
|
|
DVAX
1981
DELISTED
Dynavax Technologies
DVAX
| $8.43M | ﹤0.01% |
553,044
+56,752
| +11% | +$981K |
|
1982
Univest Financial
UVSP
$1.24B
| $8.43M | ﹤0.01% |
306,404
+31,815
| +12% | +$912K |
|
1983
Modine Manufacturing
MOD
$10.8B
| $8.42M | ﹤0.01% |
461,205
+44,808
| +11% | +$841K |
|
|
ESPR
1984
DELISTED
Esperion Therapeutics
ESPR
| $8.41M | ﹤0.01% |
214,625
+35,882
| +20% | +$1.81M |
|
|
CARB
1985
DELISTED
Carbonite Inc
CARB
| $8.4M | ﹤0.01% |
240,663
+13,656
| +6% | +$469K |
|
1986
Artivion
AORT
$1.31B
| $8.4M | ﹤0.01% |
301,474
+26,271
| +10% | +$662K |
|
1987
Lattice Semiconductor
LSCC
$19.4B
| $8.38M | ﹤0.01% |
1,277,485
+67,649
| +6% | +$388K |
|
1988
Ovintiv
OVV
$16.8B
| $8.36M | ﹤0.01% |
129,343
+7,614
| +6% | +$478K |
|
1989
RE/MAX Holdings
RMAX
$205M
| $8.36M | ﹤0.01% |
159,411
+9,131
| +6% | +$502K |
|
|
RCM
1990
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.35M | ﹤0.01% |
962,033
+154,722
| +19% | +$1.25M |
|
|
RVNC
1991
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.35M | ﹤0.01% |
304,089
+41,697
| +16% | +$1.25M |
|
|
ECYT
1992
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $8.35M | ﹤0.01% |
604,743
+219,961
| +57% | +$2.61M |
|
|
CAMP
1993
DELISTED
CalAmp Corp.
CAMP
| $8.34M | ﹤0.01% |
15,483
+1,787
| +13% | +$899K |
|
|
EIGI
1994
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $8.34M | ﹤0.01% |
838,308
+123,280
| +17% | +$1.05M |
|
1995
MasterCraft Boat Holdings
MCFT
$611M
| $8.34M | ﹤0.01% |
287,912
+25,104
| +10% | +$694K |
|
1996
Adeia
ADEA
$3.51B
| $8.32M | ﹤0.01% |
1,954,615
-36,458
| -2% | -$197K |
|
1997
Weis Markets
WMK
$1.95B
| $8.32M | ﹤0.01% |
155,950
+20,566
| +15% | +$1.02M |
|
1998
Simply Good Foods
SMPL
$1.01B
| $8.31M | ﹤0.01% |
575,511
+151,367
| +36% | +$2.03M |
|
1999
CytomX Therapeutics
CTMX
$721M
| $8.3M | ﹤0.01% |
363,128
+32,854
| +10% | +$839K |
|
2000
Omeros
OMER
$938M
| $8.3M | ﹤0.01% |
457,605
+58,000
| +15% | +$1M |
|
Similar funds
Geode Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Geode Capital Management held 4,200 positions worth $325B, up 6% from $307B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Geode Capital Management's Q2 2018 filing shows 155 new, 3,029 increased, 472 reduced and 134 closed positions. Its largest new stake was Evergy: 3,270,555 shares worth $183M. The largest sale was Time Warner Inc, an estimated $841M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2018 buy was Evergy: 3,270,555 shares worth $183M.
- Geode Capital Management added most to AT&T in Q2 2018, an estimated $479M increase.
- Geode Capital Management's biggest Q2 2018 reduction was Apple, cutting an estimated $138M.
- Geode Capital Management fully exited Time Warner Inc in Q2 2018, selling an estimated $841M.
- Geode Capital Management's ten largest holdings make up 18% of its $325B portfolio in Q2 2018.
- Geode Capital Management opened 155 new positions and closed 134 in Q2 2018.
- Geode Capital Management's portfolio value rose 6% quarter-over-quarter to $325B.
Based on Geode Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.